Agoracom Blog Home

Posts Tagged ‘Hemp’

North Bud Farms Inc. $NBUD.ca – Marijuana edibles: Is Canada on track to legalize them? $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 10:00 AM on Friday, March 29th, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information

NBUD: CSE

—————

Marijuana edibles: Is Canada on track to legalize them?

  • In a second wave of recreational legalization in Canada, cannabis edibles will be permitted for legal sale no later than Oct. 17, 2019, Health Canada has confirmed. And the market is up for grabs.
  • The edibles industry is expected to be worth $4.1 billion in Canada and the United States by 2022, according to a report by a marijuana market research company called The Arcview.

By Emanuela Campanella Multimedia Video Journalist  Global News

In a second wave of recreational legalization in Canada, cannabis edibles will be permitted for legal sale no later than Oct. 17, 2019, Health Canada has confirmed. And the market is up for grabs.

The edibles industry is expected to be worth $4.1 billion in Canada and the United States by 2022, according to a report by a marijuana market research company called The Arcview.

As of now, in Canada, you can make cannabis-infused food at home but it is illegal for anyone to buy and or sell them to the public.

Canada’s proposed edible pot regulations have been published by Health Canada and the 60-day consultation process has come to an end. The public health agency is now reviewing the responses.

The draft regulations

Under the proposed federal rules, a single serving would be limited to 10 milligrams of THC, the psychoactive ingredient in cannabis, and each serving must be individually wrapped. This is considered a low to moderate dose of THC.

This dosage limit is stricter than in Colorado, Washington or California, where multiple servings are allowed per package. So for example in a chocolate bar, each breakable square can contain 10 milligrams each for a total of 100 milligrams.

Pot meant for ingestion cannot have alcohol, have limited caffeine and come in a plain, child-resistant package. The draft regulations say the products must not be appealing to youth and the packaging can’t advertise dessert or confectionery flavours — so no gummies shaped like bears.

The proposed rules are an attempt to address one of the main concerns with edibles: making sure it doesn’t pose a risk to public health, especially for those who are underage.

“In other jurisdictions, which legalized marijuana just like the states in the U.S., one of the problems, [with] legalizing edibles, were kids. So kids came into the kitchen saw this wonderful nicely coloured marijuana edible and as kids do, try it out,” said Dr. Jürgen Rehm, a senior scientist at the Institute for Mental Health Policy Research at CAMH.

However, some are worried the black market will continue to thrive with such strict regulations. In California, for example, which legalized recreational marijuana and edibles last year, industry experts say the illicit market continues to boom. 

One major cannabis edibles manufacturer in California says it’s been difficult to navigate within the legal market because there is still so much competition in the illicit market.

“People that are heavy consumers of THC and like to ingest it, can ingest hundreds if not thousands of milligrams of THC in a day and so if they have products that are available in the illicit market that are much cheaper and have a higher potency, they’re going to tend to go towards that rather than paying significantly more for less THC, which is what they’ve used to consume,” Bryce Berryessa said, the president of La Vida Verde.

WATCH: Is marijuana good or bad for you? Everything we know about the health effects of cannabis

Berryessa says your body builds up a pretty quick tolerance when ingesting edibles. So a lot of those people who are currently used to consuming a higher amount of THC are still participating in the illegal market to get access to products with higher potencies.

Rehm who has been working on the field of mental health and cannabis consumption says it’s better to have an incremental approach when it comes to edibles.

“The problem with edible marijuana is that people are not used to it. A lot of the people once they smoke marijuana. They feel the effects pretty quickly. With edibles, the effects can be later. And people say ‘Oh, I have now done this edible marijuana and I feel nothing’ and they have more and more,” Rehm said. 

To avoid putting people at risk, it would be better to start with a low dosage and once we have clear evidence the black market is still thriving, then we can re-evaluate it, he added. 

“So with all the legislation, with all the upper limits of THC or other points, we have to be in a way so we can reap the benefits of legalization (i.e safer product and not lose some of the consumers to the black market). And frankly, I think there will be a lot of trial and error in the next one to two years.”

Health Canada confirms that they have received 7,000 responses from Canadians, industry representatives, the provinces and the public health community on the proposed edibles draft regulations. Now, the agency is reviewing the comments and considering where adjustments can be made.

Those in the marijuana industry, however, are skeptical the government will make the edibles deadline set for themselves. When it came to recreational pot, legalization was first promised on Canada day, but the actual date wasn’t for a couple of months later.

Health Canada could not comment on when we will see the updated draft but confirmed that cannabis products will be permitted for legal sale no later than Oct. 17, 2019.

Source: https://globalnews.ca/news/5096541/marijuana-cannabis-edibles-canada/

North Bud Farms Inc. $NBUD.ca – Legal #marijuana shortages persist in Canada $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 12:00 PM on Tuesday, March 26th, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information

NBUD: CSE

—————

Legal marijuana shortages persist in Canada

  • Legal cannabis shortages were still a problem in Canada in early 2019, several months after the country began recreational sales to adults, says a report this morning by broker Cowen
  • Survey of five provinces’ online weed availability in January shows that nearly half of all items remained out-of-stock on marijuana e-commerce sites

From Bill Alpert: Legal cannabis shortages were still a problem in Canada in early 2019, several months after the country began recreational sales to adults, says a report this morning by broker Cowen. A survey of five provinces’ online weed availability in January shows that nearly half of all items remained out-of-stock on marijuana e-commerce sites. But in the relatively-populous Ontario, supplies were better, with 61% of listed products actually in-stock. In New Brunswick and Newfoundland & Labrador, however, out-of-stock rates increased.

“While it is difficult to assess how much of the change is demand versus supply driven,” wrote analyst Vivien Azer, in the note, “our view is that demand remains strong with an improving supply chain.” Cowen surveyed online shops in Ontario, British Columbia, Alberta, New Brunswick and Newfoundland & Labrador.

Among Canada’s large producers, Canopy Growth (ticker: CGC) had the largest share of in-stock product on e-commerce shelves, with a 21% share in Ontario, while Aurora Cannabis (ACB) had 12% of that province’s online market. Tilray(TLRY) and Cronos Group (CRON) each had 4%.

After a month when Canada’s pot stocks mostly wandered sideways, Canopy is flat this morning, at $44.44, while Aurora is up 9% to $9.37. Tilray is up 3%, to $69, while Cronos has jumped 6.3% to $20.21, a day before it reports December-quarter results.

Dry flower marijuana made up about three-fourths of all products at Canada’s online shops, noted Cowen, with the remaining offerings consisting of capsules, oils, and pre-roll smokes.

“We continue to believe that the category will look very different in late 2019,” the analyst wrote, “when vapor, beverages, edibles, and other form factors become available.”

Prices for dry flower held firm in January, according to Cowen, at $10.22 Canadian dollars per gram (or US$7.56). Pre-roll product commands a price premium, for its convenience, but Canadian consumers had cause to celebrate, as pre-roll’s average price fell 4% from December, to C$12.88 a gram.

Source: https://etfdailynews.com/2019/03/25/legal-marijuana-shortages-persist-in-canada/

Marijuana Company of America $MCOA Enters Strategic Partnership with Massroots to Promote the hempSMART CBD Product Line $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca $MSRT

Posted by AGORACOM-JC at 8:12 AM on Tuesday, March 26th, 2019
  • Announced that the Company’s wholly owned subsidiary hempSMART™ has entered into a strategic marketing agreement with MassRoots, Inc. (OTCQB: MSRT) to promote its hemp CBD formulated product line.
  • Under the terms of the agreement, MassRoots agreed to participate as an associate in the Company’s associate marketing platform, to help promote and sell hempSMART™ products on www.massroots.com, as well as MassRoots’ app and other social media outlets.

Escondido, California–(March 26, 2019) – MARIJUANA COMPANY OF AMERICA INC. (OTCQB: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that the Company’s wholly owned subsidiary hempSMART™ has entered into a strategic marketing agreement with MassRoots, Inc. (OTCQB: MSRT) to promote its hemp CBD formulated product line.

Under the terms of the agreement, MassRoots agreed to participate as an associate in the Company’s associate marketing platform, to help promote and sell hempSMART™ products on www.massroots.com, as well as MassRoots’ app and other social media outlets.

“We’re excited to begin educating MassRoots’ community of over a million cannabis consumers about hempSMART’s™ innovative line of CBD products,” stated MassRoots’ Chief Executive Officer Isaac Dietrich. “We look forward to driving our audience to a company that focuses on providing consumers with the highest-quality of ingredients and products, which is ultimately why we’re partnering with MCOA.”

CEO of MCOA, Donald Steinberg, stated, “We are very proud to have the hempSMART™ CBD product line accepted by MassRoots as part of their marketing campaign. We are anticipating increased visibility for our product line by utilizing such a widely recognized media platform involved in the cannabis industry.”

About MassRoots

MassRoots, Inc. is a leading technology platform for the regulated cannabis industry. Powered by more than one million registered users, the Company’s mobile apps empower consumers to make educated cannabis purchasing decisions through community-driven reviews. Its rewards program, WeedPassTM, enables consumers to earn tickets to movies, sporting events, and festivals by shopping at participating dispensaries. MassRoots has been covered by CNN, CNBC, Fox Business, Fortune, Forbes, and Reuters. For more information, please visit www.MassRoots.com/Investors and review MassRoots’ filings with the U.S. Securities and Exchange Commission.

About Marijuana Company of America, Inc.

MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWire/MCOA

Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

North Bud Farms Inc. $NBUD.ca – CBD is booming. But US farmers struggle to keep up with demand for industrial hemp $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 12:25 PM on Monday, March 25th, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information

NBUD: CSE

—————

CBD is booming. But US farmers struggle to keep up with demand for industrial hemp

  • Retail sales of cannabis-compound CBD are expected to reach $16 billion by 2025, according to Cowen.
  • Growing industrial hemp is incredibly expensive and inefficient. Lab tests aren’t always accurate.
  • Retailers are receiving a flood of pitches as people try to take advantage of the so-called green rush.

Angelica LaVito | @angelicalavito

Geoffroy Van Der Hasselt | AFP | Getty Images Oils containing CBD (Cannabidiol) are seen in a shop in Paris on June 14, 2018.

It’s Hollywood’s new favorite beauty product. It’s the superfood du jour. Demand for CBD is so strong that companies are scrambling to infuse their products with it, but the CBD they’re finding isn’t all that great.

Congress legalized industrial hemp in December. With it, they also legalized hemp-derived CBD, short for cannabidiol, a cannabis compound that supposedly delivers the calming effects of marijuana without the high from THC.

Last year, retail sales of CBD consumer products in the U.S. were estimated at between $600 million and $2 billion, according to investment research firm Cowen. The bank conservatively forecasts sales to reach $16 billion by 2025, with health and wellness products leading the way and food, beverage, beauty and vapor to also play a role.

From seed to CBD

The current supply chain — from plants, to extraction, to labs — is riddled with issues. And the nascent industry is trying to work through the kinks at the same time demand is ramping up, leaving producers frustrated and consumers stuck trying to sift good products from bad ones.

“There are huge challenges to producing the industrial hemp required for meeting the demand,” said George Weiblen, a professor at the University of Minnesota who has been studying cannabis since 2002. “It’s not as simple as growing tomatoes. It’s just not. … The possibility of failure to produce quality cannabis extracts is huge.”

Decades of modern farming techniques have tamed staple crops like corn and wheat. Farmers know what to expect when they plant these crops and can follow a pretty straightforward set of guidelines when they grow them. With hemp for CBD, not so much.

More religion than science

People have been growing hemp illegally for years. Farmers have kept their operations quiet and developed their own techniques that are all a little different, said Christian Cypher, a senior vice president at Pyxus International who is leading the agriculture company’s cannabis work.

“Growing hemp has been more religion than science,” he said.

Most hemp farmers are growing the plant like a tomato, a process that’s expensive and intensive, said David Williams, an agronomist at the University of Kentucky who studies hemp. This model works for marijuana because you want the flower to look and smell nice. For hemp that will be used to extract CBD, this system is incredibly expensive and unnecessary since you only care about what’s inside the flower, Williams said.

“If the molecule is of interest and becomes broadly distributed, it will need to be far more efficient than what we have today,” he said.

Incredibly expensive

Industrial hemp produces such small amounts of CBD that growing it and harvesting it to extract the molecule is incredibly expensive. One Canadian certified industrial hemp strain produced an average of 0.6 percent CBD and 0.03 percent THC, according to a study Weiblen conducted.

Arcadia Biosciences, a company that has bred wheat to be more fibrous, recently entered the cannabis space with the aim of growing hemp that produces more CBD and no or reliably low THC. Federal law says CBD is legal so long as it contains less than 0.3 percent THC.

“We think that’s a significant opportunity,” said Matt Plavan, chief financial officer of Arcadia and president of the new cannabis-focused unit, Arcadia Specialty Genomics.

A ‘green rush’

Farmers won’t find out how much THC their plants produce until they’re harvested, dried and the CBD is extracted. During this process, the CBD becomes concentrated and the THC gets dragged along with it, Weiblen said, possibly to the point where the amount of THC exceeds the legal limit.

With CBD coming into vogue, some are latching onto the trend and cutting corners along the way.

Numerous studies, including from federal regulators, have found a slew of products don’t contain the amount of CBD they say they do.

There aren’t any federal laws requiring companies to test CBD, whether it goes into beauty or food products. Some farmers or manufacturers send their extracts in anyway, and they’re learning that lab tests are working through a similar learning curve as the rest of the supply chain.

Vastly different results

Chris Padulo, a farmer in Vermont who started growing hemp last year, sent samples to four different labs and got “vastly different results” from each. One lab said the plant he sent in contained 8 percent CBD. Another one said it contained 16 percent. The two others said it landed somewhere in the middle.

“I figured science is science,” he said. “There are no consistencies.”

Retailers say they’re constantly receiving pitches from people asking to put their products on shelves. Chris Burton, retail partner manager at online CBD store HelloMD, grills brands on where their hemp is grown, how the CBD is extracted, where their lab tests are and more.

Wild West

“Some say their CBD is the best possible and when you ask how they know they can’t answer questions,” Burton said.

Consumers shopping for CBD will find a slew of terms: isolate, full spectrum, water soluble and more, with each claiming to be better than the other. Brands are trying to differentiate themselves and prove their products are legit, especially as they introduce people to an entirely new category.

Burton says this “green rush” worries him that people seeing dollar signs are moving as fast they can to brings products to market.

“It’s really just the wild west out there,” he said.

Source: https://www.cnbc.com/2019/03/23/cbd-is-booming-but-us-farmers-struggle-to-keep-up-with-demand.html

Empower Clinics $EPW.ca gleans key patient insights from its artificial intelligence pilot program $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 8:57 PM on Tuesday, March 19th, 2019
  • Company is working with Canntop AI to identify insights for improvements to physician recommended treatment plans
  • “Insights derived from artificial intelligence are beginning to demonstrate how patients in our key markets are talking about or describing their experience and ideas related to cannabis/CBD-based treatments, and even suggesting recommendations about alternative therapies and their effectiveness in treating a wide array of qualifying conditions,” Empower CEO Steven McAuley said in a statement.

Empower owns and operates a vast network of physician-staffed clinics focused on helping patients through medical cannabis

Empower Clinics Inc (OTCMKTS:EPWCF) (CSE:EPW) told investors Tuesday that the artificial intelligence tools supplied by Canntop AI, a subsidiary of Datametrex AI Limited, was helping the medical cannabis company sift through mountains of data to create “actionable insights,” with the aim of improving patient care.

“Insights derived from artificial intelligence are beginning to demonstrate how patients in our key markets are talking about or describing their experience and ideas related to cannabis/CBD-based treatments, and even suggesting recommendations about alternative therapies and their effectiveness in treating a wide array of qualifying conditions,” Empower CEO Steven McAuley said in a statement.

The Vancouver cannabis company said it provided crucial SEO terms and phrases which Canntop integrated into the artificial intelligence platform so Empower could get more insights about its two largest markets in Portland and Phoenix. The whole idea rests on gaining “actionable insights” on how consumer social data is generating interest in CBD-based products, alternative pain management, and the use of cannabis-based therapies, said the company. 

“We believe the outcomes of our AI efforts, if successful, could position the company as an educational leader,” said McAuley. “We plan to collaborate with the industry with the ultimate goal of improving patient care.”

Artificial intelligence eliminates tedious data-sorting chores, and with machines using algorithms, it give them superhuman learning powers. Ultimately, AI gives companies like Empower, the tools to make faster, more accurate decisions after acquiring information about patients.

Powerful AI tools change the equation

“Canntop’s powerful AI tools are helping us analyze the substantial amounts of data in the Empower database and we expect will facilitate the integration of the additional data we expect to derive from the proposed acquisition of the Sun Valley Clinic group, that has a combined 165,000 patients,” said McAuley.

Empower has struck a non-binding deal to acquire the business of the Sun Valley Holdings, which operates a network of medical cannabis and pain management practices, with clinics in Arizona and Las Vegas as well as a tele-medicine platform serving California.

Empower utilizes a patient electronic management system that is HIPAA compliant and provides deep insight to patient care. The company’s tele-medicine platform also supports remote patients who use its portal when they are unable to come to a location, but still benefit from a doctor consultation.

“We are thrilled that Empower chose Canntop AI to be their partner for their artificial Intelligence needs. This is a great validation for our business model,” said Michael Frank, Chief Strategy Officer at Datametrex. “We believe this alliance between Canntop and Empower will create a strong platform for data analysis in the cannabis sector especially in the US, providing insurers and health care providers an ideal solution for patient care.”

Empower is a leading owner and operator of a network of physician-staffed clinics focused on helping patients improve their health through the use of medical cannabis.

Separately, Empower has also started selling its own line of CBD-based products called Sollievo via its network of company-owned clinics in the US. The offerings include CBD lotion, tinctures, spectrum oils, capsules, lozenges, patches, topical lotions, gel caps, e-drinks, hemp extract drops and pet elixir hemp extract drops.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

Source: https://ca.proactiveinvestors.com/companies/news/216765/empower-clinics-gleans-key-patient-insights-from-its-artificial-intelligence-pilot-program-216765.html

INTERVIEW: NORTHBUD $NBUD.ca Discusses Binding LOI For Acquisition of Multi-State Licensed Operator Eureka Vapor $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 1:37 PM on Tuesday, March 12th, 2019

NORTHBUD (NBUD:CSE) is already a late stage applicant at the “Confirmation of Readiness” stage for 25,000 square feet of indoor and 500,000 square feet of outdoor growing space, for the sole purpose of growing GMP pharma-grade cultivation and food-grade extracted inputs.

But Ryan Brown didn’t get this far in the cannabis space by sitting still … and he has made one hell of a great deal with the $20 MILLION acquisition of Eureka Vapor, a multi-state licensed operator in the USA.  The acquisition is subject to typical closing and due diligence but Ryan has a close relationship with the CEO and is confident it will close.

If and when it does close, Eureka will bring about $11.5 million in revenue at a 16% profit margin, which will be immediately accretive to the bottom line of NORTHBUD.  Accretive is actually an understatement.

I also love this acquisition because of its’ terms, which shows the confidence that both sides have in each other.  For example, the Eureka team can earn an extra $25 million if they hit certain milestones.  That says a lot about how Eureka may grown once it is a part of NORTHBUD.

On the flipside, the Eureka group only gets 10% of their shares on closing, with the rest dripped out over the next 24 months. That says a lot about the confidence Eureka has in NORTHBUD.

Find out more about NORTHBUD and this great deal in this interview with Ryan, who has already made a name for himself and is now on his way to growing that success, pun intended.

North Bud Farms $NBUD.ca Clarifies Terms of Binding Letter of Intent to Enter U.S. Market with Strategic Acquisition of Multi-State Licensed Operator Eureka Vapor $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 4:35 PM on Thursday, March 7th, 2019
  • Clarifies the terms of its press release dated March 6, 2019 with respect to entering into the March 3, 2019 binding letter of intent

TORONTO, March 07, 2019 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company”) clarifies the terms of its press release dated March 6, 2019 with respect to entering into the March 3, 2019 binding letter of intent (“LOI”) to acquire all the issued and outstanding shares of Eureka Vapor LLC. and all of its subsidiaries (“Eureka”), a U.S. multi-state cannabis operator, and arm’s length to the Company, in a transaction valued at CAD$20 million (the “Transaction”). The completion of the Transaction is subject to the following conditions precedent: (i) obtaining the necessary board of director and shareholder approval of the Company and Eureka; (ii) the Company and Eureka satisfying respective due diligence of the other on or before May 30, 2019; (iii) entering into of a definitive agreement (the “Definitive Agreement”) in respect of the Transaction; and (iv) obtaining necessary regulatory and CSE approval. The Company and Eureka shall use commercially reasonable best efforts to satisfy the aforementioned condition precedents as soon as possible, but in any event no later than June 1, 2019 (the “Termination Deadline”) or another date as may be agreed to by the parties. In the event that the conditions precedent have not been satisfied or waived prior to the Termination Deadline, the LOI will automatically terminate.

As referenced in its March 6, 2019 press release, the purchase price of Eureka under the Definitive Agreement will be satisfied by the issuance of common shares (“Common Shares”) of the Company to Eureka shareholders with a price per Common Share to be determined based on a formula of the higher of (a) CAD$0.35 per Common Share; and (b) the 30 day volume weighted average price of the Common Shares. 10% of the Common Shares will be issued to the Eureka shareholders on the closing date of the Transaction (the “Closing Date”), with the remainder of Common Shares issued in equal tranches of six, twelve, eighteen, and twenty-four months from the Closing Date. In addition, Eureka shareholders are eligible to receive up to an additional CAD$25 million of Common Shares based on the achievement of USD$25 million of revenue derived from existing Eureka California and Colorado operations.

The 10% of the Common Shares issued on the Closing Date will represent up to 9.33% of the total issued and outstanding Common Shares on the Closing Date (if the minimum issuance price of CAD$0.35 per Common Share is assumed and there is no occurrence of dilutive events). The Company will issue a comprehensive press release respecting the terms of the Definitive Agreement upon entering into the Definitive Agreement.

The Company anticipates its common shares will re-commence trading after the dissemination of this news release.
           
About Eureka Vapor LLC.
Headquartered in Los Angeles, California, EUREKA Vapor was founded in 2011 and holds licenses in both California and Colorado.  EUREKA Vapor’s multi state operation manufactures and sells a premium line of vaporizer cartridges, disposable vapor pens and proprietary vaporizer batteries designed to work with their highly sought-after CO2 extracted oil.  Using their refined extraction processes and techniques developed over almost a decade of extracting, EUREKA Vapor is committed to providing the cleanest and safest natural oil cartridges in the industry.  Long referred to as one of the leaders in the industry, EUREKA has one of the most loyal customer bases in the category which reflects their commitment to honesty and transparency above all else. EUREKA continually looks for innovative ways to improve and refine their product offerings in order to deliver the best, most consistent vaping experience in the industry. 

For more information visit: www.eurekavapor.com

About North Bud Farms Inc.
North Bud Farms Inc., through its wholly-owned subsidiary GrowPros MMP Inc., is pursuing a licence under The Cannabis Act.  The Company is constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of Agricultural Land in Low, Quebec. North Bud Farms Inc. will be focused on Pharmaceutical and Food Grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October 2019.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward- looking statements including those relating to the Transaction, the completion of conditions precedent to the Transaction, entering into of the Definitive Agreement, the potential termination of the LOI, the issuance of Common Shares to Eureka shareholders, an issuance price of CAD$0.35 per Common Share at the Closing Date, Eureka achieving USD$25 million of revenue derived from California and Colorado operations, and the issuance of up to CAD$25 million of Common Shares, and the re-commencement of the trading of common shares of the Company. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Such risks and uncertainties include, among others, the risk factors included in North Bud Farms Inc.’s final long form prospectus dated August 21, 2018 which is available under the issuer’s SEDAR profile at www.sedar.com.  

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

CLIENT FEATURE: Bougainville Ventures $BOG.ca a Turnkey Greenhouse Growing Infrastructure Provider $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 5:11 PM on Monday, March 4th, 2019

BOG: CSE

  • Landlord for licensed marijuana growers in the United States
  • Brilliant business plan that removes all risk and appeals to traditional real estate investors
  • Bougainville does not “touch the plant” by only providing agricultural infrastructure to tenants
  • Converts irrigated farmland to greenhouse-equipped farmland
  • Signed Second Tenant for 21,000 SQF Lease
  • Ready for occupancy
  • Room for expansion
  • JV Agreement with Marijuana Company of America (MCOA:OTC)
  • MCOA invested $1M in cash

Early estimates show a greenhouse can produce twice the amount of product and at least
less than 50% of the cost compared to warehouse production.

Oroville, Washington

  • Construction complete of greenhouse optimized for low-carbon and sustainable operations
  • Facility projected to produce in excess of 12,000 lbs. of high quality cannabis per annum upon completion of all greenhouses
  • I-502 compliant property ready for tenant-grower occupancy
  • Entered into an agreement with Green Venture Capital Corp., to purchase the balance of a 4 acre property
  • 50% + senior water right holder on the main stem of the Eden Valley Aquifer and two supplemental groundwater wells
  • Entered into a lease agreement with a Tier 3 I-502 production and processing license holder
  • Leadership has local farming knowledge and relationships 
  • Room for further expansion

Turnkey Growing Facilities

Development Phases

Hub On AGORACOM

FULL DISCLOSURE: Bougainville Ventures is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: North Bud Farms $NBUD.ca sustainable low cost, high quality cannabinoid production and procurement $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 1:53 PM on Monday, March 4th, 2019

WHY NORTHBUD FARMS?

  • Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year
    As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
  • Infused products sector has become the highest margin segment of the industry
  • Positioned to be a raw input producer for this space
  • Currently working with multiple food, beverage and science companies to provide safe standardized cannabinoid infused raw inputs for large scale GMP manufacturing of products
  • Announced Creation of “1017” Distribution and Signing of a LOI to Acquire Janey’s Cannabis Line

THE OPPORTUNITY

  • Acquired late stage ACMPR applicant GrowPros MMP from Tetra Bio-Pharma (TSXV: TBP)
  • GrowPros MMP application was submitted in November 2014 and is currently in the ‘Confirmation of Readiness’ stage.
  • Announced the amendment of its licence application to add 500K SQ. FT. of outdoor cultivation area
  • Phase 1 is located on 95 acres of agricultural farmland in Low, Québec.
  • Option exists to acquire more land if needed
  • Facility will focus on GMP (higher production grade) pharma-grade cultivation and food-grade extracted inputs

CHECK OUT OUR RECENT INTERVIEW

FULL DISCLOSURE: North Bud Farms is an advertising client of AGORA Internet Relations Corp.

North Bud Farms $NBUD.ca Upgrades to OTCQB to Engage and Expand U.S. Investor Audience $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 8:57 AM on Monday, March 4th, 2019
  • Company have been approved for and will commence trading on the OTCQB venture marketplace, operated by OTC Markets Group, under the ticker symbol NOBDF.
  • The Company also announced its strategy to create greater opportunity for its shareholders and attract new U.S. retail and institutional investors by providing transparency via this listing.

TORONTO, March 04, 2019 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company”) today announced that effective today, shares of the Company have been approved for and will commence trading on the OTCQB venture marketplace, operated by OTC Markets Group, under the ticker symbol NOBDF. The Company also announced its strategy to create greater opportunity for its shareholders and attract new U.S. retail and institutional investors by providing transparency via this listing.

“We are extremely pleased to announce our listing to the OTCQB Venture Marketplace,” said Ryan Brown, CEO of North Bud Farms Inc.  “NORTHBUD is committed to the high level of financial and corporate disclosure that is required for this listing category which further demonstrates significant improvement in how we are categorized in the public markets. This move represents our expansion in growing our U.S. investor shareholder base as we believe that trading on the OTCQB will enhance trading liquidity and continue to increase market adoption of our business model, thereby enhancing shareholder value.” 

The OTCQB is considered by the SEC as an established public market for the purpose of determining the public market price when registering securities for resale with the SEC. The OTCQB dramatically increases transparency, reporting standards, management certification and compliance requirements, the majority of broker dealers trade stocks on the OTCQB. Historically this has resulted in greater liquidity and awareness for companies that reach the OTCQB tier.

McMillan LLP serves as NORTHBUD’s OTCQB advisor, responsible for providing professional guidance on OTCQB requirements and U.S. securities laws. U.S. investors can find current financial disclosure and quotes for the company on www.otcmarkets.com.

About North Bud Farms Inc.
North Bud Farms Inc., through its wholly owned subsidiary GrowPros MMP Inc. which was acquired in February 2018, is pursuing a licence under The Cannabis Act.  North Bud Farms Inc. is constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of Agricultural Land in Low, Quebec. North Bud Farms Inc. will be focused on Pharmaceutical and Food Grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October 2019.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward- looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Such risks and uncertainties include, among others, the risk factors included in North Bud Farms Inc.’s final long form prospectus dated August 21, 2018 which is available under the issuer’s SEDAR profile at www.sedar.com. 

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]